Data governance
Purpose limitation, minimum necessary data, lawful access, de-identification, secure transfer, role-based access, retention, deletion, and incident response.
Transparency · Governance · Trust
A single source for how microscopIA approaches data, pricing, partnerships, authorship, publication, research integrity, and innovation responsibility.
Project-specific agreements remain authoritative when their terms are more specific than this public framework.
Public governance framework
The same framework supports institutional, clinician-led, education-supported, and innovation projects.
Purpose limitation, minimum necessary data, lawful access, de-identification, secure transfer, role-based access, retention, deletion, and incident response.
Feasibility, protocol quality, ethics, reproducibility, conflicts, reporting, correction pathways, and protection from inappropriate practices.
Authorship is earned through documented contribution and accountability. Payment or project access does not confer authorship.
Journal strategy, indexing, processing charges, peer-review risk, editorial independence, and no acceptance guarantee are stated clearly.
Every agreement defines responsibilities, deliverables, timelines, decision rights, confidentiality, data permissions, financial terms, and termination.
Clinical AI and devices require defined intended use, human oversight, validation, monitoring, and project-specific IP terms. AI may support triage and prioritisation; diagnosis and care decisions remain human responsibilities.
Clinical data governance
Do not submit identifiable patient data through a general contact form. Work begins only after the data source, authority, permitted purpose, safeguards, and responsibilities are established.
Confirm provenance, controller, permissions, ethics, variables, criteria, and secure transfer.
Use minimum necessary data, role-based access, documented transformations, reproducibility, and confidentiality.
Apply retention or deletion terms, preserve approved records, document outputs, and prevent unapproved reuse.
Pricing transparency
One scientific standard, with Colombia pricing in COP and Americas and international pricing in USD. Prices apply to a complete, ready-to-start research package and are confirmed after feasibility review.
Colombia: more than 80% of submitter authors must hold Colombian affiliations and the proposal must arrive by day 10 of the call cycle. Americas: more than 80% must hold affiliations in countries of the Americas outside Colombia and the proposal must arrive by day 10. Americas prices are fixed commercial rates exactly USD 100 above the USD reference for each Colombia tier (fixed COP 4,000/USD basis; not a live currency conversion). Otherwise, the international rate applies.
Outcome-aligned payment
The fee contributes to team salaries and the eligible article processing charge; microscopIA absorbs the remaining delivery cost. This model aligns incentives but cannot control an independent journal decision.
Due after microscopIA approves the proposal and the agreement is signed. Work begins after receipt.
Due only after formal acceptance for publication. If none of the five-journal pathway accepts the manuscript, the second payment is not due.
USD 150 for each qualifying submitter author above the included limit. Colombian projects are invoiced in the COP equivalent.
From ready-to-start confirmation to manuscript submission
Priority delivery in 4 weeks
Case reports only: rapid delivery in 10 business days
The clock starts after ethics/authorization review, a complete analysable dataset or case file, variable dictionary, contributor details, secure-transfer approval, and first payment. It pauses while essential partner input is outstanding. Journal peer review and acceptance are excluded.
Partnership models
Each project uses the model that best reflects who contributes data, scientific work, infrastructure, funding, oversight, technology, or implementation capacity.
The submitter provides governed data and clinical expertise; microscopIA leads the remaining scientific workflow; both teams publish together.
Scope, fee, deliverables, decision rights, and publication pathway are agreed in writing.
Participation fees support training, supervision, infrastructure, and eligible publication costs—not authorship.
Development, validation, IP, inventor recognition, licensing, and publication rights are project-specific.
A recurring model supports portfolio selection, protocols, analytics, publishing, and internal capacity.
Chapter development and medical-book editing are available by request and priced after an editorial assessment.
Corporate verification
A current Chamber of Commerce certificate is still required for independent confirmation of the representative and current status.
Verify in RUES ↗Research-group reference: Minciencias Convocatoria 894 of 2021 · code COL0221032 · microscopIA SAS. This historical call reference is not a claim of current classification. Minciencias ↗
External affiliations identify individual contributors and do not imply institutional endorsement or a formal partnership unless expressly stated.
Trust Center FAQ
No. Journals retain independent authority. The second 50% is due only after acceptance to align payment with the intended outcome.
Yes. microscopIA pays 100% of an eligible mandatory article processing charge for the approved journal directly after acceptance and invoice verification. Optional services are excluded unless agreed.
Only when permissions, ethics, the written agreement, and purpose allow it. A new question does not create automatic authority.
Concerns are documented and reviewed. Action can include revision, role changes, suspension, termination, correction, or institutional escalation.
microscopIA evaluates the decision, improves and reformats the work, and may submit sequentially to as many as five appropriate journals. A sixth pathway requires a new written scope.
Clarity before commitment
A formal collaboration may require a scope, data terms, authorship plan, participation terms, IP schedule, and financial proposal.